Literature DB >> 35303274

Efficacy of myocardial washout of 99mTc-MIBI/Tetrofosmin for the evaluation of inflammation in patients with cardiac sarcoidosis: comparison with 18F-fluorodeoxyglucose positron emission tomography findings.

Masataka Suzuki1, Yu Izawa2, Hiroshi Fujita1, Keisuke Miwa1, Yu Takahashi1, Hiroyuki Toh1, Takayoshi Toba1, Sei Fujiwara1, Hiromi Hashimura3, Atsushi K Kono3, Ken-Ichi Hirata1.   

Abstract

OBJECTIVE: Both myocardial perfusion scintigraphy and 18F-fluorodeoxyglucose positron emission tomography (FDG PET) are useful for the diagnosis of cardiac sarcoidosis (CS). However, the association between the washout of 99mTc-labeled tracer and FDG PET has not been established. This study aimed to evaluate the association between the washout of 99mTc-labeled tracer and FDG PET findings in patients with CS.
METHODS: We retrospectively analyzed 64 patients (65.0 ± 11.2 years, 53% male) with suspected CS who underwent myocardial single-photon emission computed tomography (SPECT) with 99mTc-labeled tracer and FDG PET. The SPECT images were acquired at 15 min (early images) and 3 h (delayed images) after injection and scored visually using a 17-segment model with a 5-point scoring system. The washout score was defined as the difference between the early and delayed total defect scores. FDG positivity was considered as focal or focal on diffuse patterns on visual assessment, and FDG uptake was quantified by measuring the standardized uptake value (SUV) of each of the 17 segments.
RESULTS: The washout score was significantly higher for the CS group than for the non-CS group (3.0 [-1.0-5.0] vs. 0.0 [-0.5-1.0], p = 0.010). Receiver operating characteristic analysis showed that a washout score of ≥ 2 had the best accuracy for detecting CS (88% sensitivity and 56% specificity) and FDG positivity (71% sensitivity and 89% specificity). In the segment-based analysis of 833 segments from 49 patients, excluding 15 patients with diffuse FDG uptake, the median SUVs for FDG uptake for the washout scores of ≤ 0, 1, and 2 were 2.3 (1.8-3.6), 4.2 (2.9-7.8), and 8.3 (6.5-9.4), respectively (p < 0.001).
CONCLUSIONS: The washout of 99mTc-labeled tracer can be a useful marker for the evaluation of FDG PET findings in patients with CS.
© 2022. The Author(s) under exclusive licence to The Japanese Society of Nuclear Medicine.

Entities:  

Keywords:  99mTc-labeled tracer; Cardiac sarcoidosis; FDG PET; SPECT; Washout

Mesh:

Substances:

Year:  2022        PMID: 35303274     DOI: 10.1007/s12149-022-01735-7

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  5 in total

1.  Technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 uptake in rat myocardial cells.

Authors:  A S Arbab; K Koizumi; K Toyama; T Arai; T Araki
Journal:  J Nucl Med       Date:  1998-02       Impact factor: 10.057

2.  Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis.

Authors:  Wataru Okumura; Tsutomu Iwasaki; Takuji Toyama; Tatsuya Iso; Masashi Arai; Noboru Oriuchi; Keigo Endo; Tomoyuki Yokoyama; Tadashi Suzuki; Masahiko Kurabayashi
Journal:  J Nucl Med       Date:  2004-12       Impact factor: 10.057

3.  Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations.

Authors:  A Perry; F Vuitch
Journal:  Arch Pathol Lab Med       Date:  1995-02       Impact factor: 5.534

4.  Gallium-67 scanning to stage the alveolitis of sarcoidosis: correlation with clinical studies, pulmonary function studies, and bronchoalveolar lavage.

Authors:  B R Line; G W Hunninghake; B A Keogh; A E Jones; G S Johnston; R G Crystal
Journal:  Am Rev Respir Dis       Date:  1981-04

5.  (99m)Tc-MIBI Washout Rate to Evaluate the Effects of Steroid Therapy in Cardiac Sarcoidosis.

Authors:  Masayoshi Sarai; Sadako Motoyama; Yasuchika Kato; Hideki Kawai; Hajime Ito; Kayoko Takada; Ryuji Yoda; Hiroshi Toyama; Shin-Ichiro Morimoto; Yukio Ozaki
Journal:  Asia Ocean J Nucl Med Biol       Date:  2013
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.